These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 30576655)

  • 1. USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors.
    Lim KS; Li H; Roberts EA; Gaudiano EF; Clairmont C; Sambel LA; Ponnienselvan K; Liu JC; Yang C; Kozono D; Parmar K; Yusufzai T; Zheng N; D'Andrea AD
    Mol Cell; 2018 Dec; 72(6):925-941.e4. PubMed ID: 30576655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Stranded DNA Gap Accumulation Is a Functional Biomarker for USP1 Inhibitor Sensitivity.
    da Costa AA; Somuncu O; Ravindranathan R; Mukkavalli S; Martignetti DB; Nguyen H; Jiao Y; Lamarre BP; Sadatrezaei G; Moreau L; Liu J; Iyer DR; Lazaro JB; Shapiro GI; Parmar K; D'Andrea AD
    Cancer Res; 2024 Oct; 84(20):3435-3446. PubMed ID: 38885312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Tumors.
    Cadzow L; Brenneman J; Tobin E; Sullivan P; Nayak S; Ali JA; Shenker S; Griffith J; McGuire M; Grasberger P; Mishina Y; Murray M; Dodson AE; Gannon H; Krall E; Hixon J; Chipumuro E; Sinkevicius K; Gokhale PC; Ganapathy S; Matulonis UA; Liu JF; Olaharski A; Sangurdekar D; Liu H; Wilt J; Schlabach M; Stegmeier F; Wylie AA
    Cancer Res; 2024 Oct; 84(20):3419-3434. PubMed ID: 39402989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer.
    Simoneau A; Engel JL; Bandi M; Lazarides K; Liu S; Meier SR; Choi AH; Zhang H; Shen B; Martires L; Gotur D; Pham TV; Li F; Gu L; Gong S; Zhang M; Wilker E; Pan X; Whittington DA; Throner S; Maxwell JP; Chen Y; Yu Y; Huang A; Andersen JN; Feng T
    Mol Cancer Ther; 2023 Feb; 22(2):215-226. PubMed ID: 36228090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cells.
    Cybulla E; Wallace S; Meroni A; Jackson J; Agashe S; Tennakoon M; Limbu M; Quinet A; Lomonosova E; Noia H; Tirman S; Wood M; Lemacon D; Fuh K; Zou L; Vindigni A
    Nucleic Acids Res; 2024 Aug; 52(15):8861-8879. PubMed ID: 38943334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours.
    Dibitetto D; Liptay M; Vivalda F; Dogan H; Gogola E; González Fernández M; Duarte A; Schmid JA; Decollogny M; Francica P; Przetocka S; Durant ST; Forment JV; Klebic I; Siffert M; de Bruijn R; Kousholt AN; Marti NA; Dettwiler M; Sørensen CS; Tille JC; Undurraga M; Labidi-Galy I; Lopes M; Sartori AA; Jonkers J; Rottenberg S
    Nat Commun; 2024 May; 15(1):4430. PubMed ID: 38789420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCAF-Mediated Histone Acetylation Promotes Replication Fork Degradation by MRE11 and EXO1 in BRCA-Deficient Cells.
    Kim JJ; Lee SY; Choi JH; Woo HG; Xhemalce B; Miller KM
    Mol Cell; 2020 Oct; 80(2):327-344.e8. PubMed ID: 32966758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair.
    Kais Z; Rondinelli B; Holmes A; O'Leary C; Kozono D; D'Andrea AD; Ceccaldi R
    Cell Rep; 2016 Jun; 15(11):2488-99. PubMed ID: 27264184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTIP UFMylation promotes replication fork degradation in BRCA1-deficient cells.
    Tan Q; Xu X
    J Biol Chem; 2024 Jun; 300(6):107312. PubMed ID: 38657865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function analysis of USP1: insights into the role of Ser313 phosphorylation site and the effect of cancer-associated mutations on autocleavage.
    Olazabal-Herrero A; García-Santisteban I; Rodríguez JA
    Mol Cancer; 2015 Feb; 14(1):33. PubMed ID: 25744535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells.
    Yazinski SA; Comaills V; Buisson R; Genois MM; Nguyen HD; Ho CK; Todorova Kwan T; Morris R; Lauffer S; Nussenzweig A; Ramaswamy S; Benes CH; Haber DA; Maheswaran S; Birrer MJ; Zou L
    Genes Dev; 2017 Feb; 31(3):318-332. PubMed ID: 28242626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear antigen (PCNA) through Its interactions with PCNA and USP1.
    Lee KY; Yang K; Cohn MA; Sikdar N; D'Andrea AD; Myung K
    J Biol Chem; 2010 Apr; 285(14):10362-9. PubMed ID: 20147293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells.
    Hromas R; Kim HS; Sidhu G; Williamson E; Jaiswal A; Totterdale TA; Nole J; Lee SH; Nickoloff JA; Kong KY
    Breast Cancer Res; 2017 Nov; 19(1):122. PubMed ID: 29145865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insert L1 is a central hub for allosteric regulation of USP1 activity.
    Dharadhar S; van Dijk WJ; Scheffers S; Fish A; Sixma TK
    EMBO Rep; 2021 Apr; 22(4):e51749. PubMed ID: 33619839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells.
    Noordermeer SM; van Attikum H
    Trends Cell Biol; 2019 Oct; 29(10):820-834. PubMed ID: 31421928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cockayne syndrome group B protein regulates fork restart, fork progression and MRE11-dependent fork degradation in BRCA1/2-deficient cells.
    Batenburg NL; Mersaoui SY; Walker JR; Coulombe Y; Hammond-Martel I; Wurtele H; Masson JY; Zhu XD
    Nucleic Acids Res; 2021 Dec; 49(22):12836-12854. PubMed ID: 34871413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
    Cong K; Peng M; Kousholt AN; Lee WTC; Lee S; Nayak S; Krais J; VanderVere-Carozza PS; Pawelczak KS; Calvo J; Panzarino NJ; Turchi JJ; Johnson N; Jonkers J; Rothenberg E; Cantor SB
    Mol Cell; 2021 Aug; 81(15):3128-3144.e7. PubMed ID: 34216544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The USP1/UAF1 complex promotes double-strand break repair through homologous recombination.
    Murai J; Yang K; Dejsuphong D; Hirota K; Takeda S; D'Andrea AD
    Mol Cell Biol; 2011 Jun; 31(12):2462-9. PubMed ID: 21482670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication.
    Tarsounas M; Sung P
    Nat Rev Mol Cell Biol; 2020 May; 21(5):284-299. PubMed ID: 32094664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps.
    Taglialatela A; Leuzzi G; Sannino V; Cuella-Martin R; Huang JW; Wu-Baer F; Baer R; Costanzo V; Ciccia A
    Mol Cell; 2021 Oct; 81(19):4008-4025.e7. PubMed ID: 34508659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.